Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2015
03/05/2015WO2015028094A1 Branimycin derivatives and their use for the treatment of bacterial infectious diseases
03/05/2015WO2015027963A1 Aromatic ring derivative, and pharmaceutical composition and use thereof
03/05/2015WO2015027949A1 Application of deuterated fumaric acid derivatives in treatment of multiple sclerosis
03/05/2015WO2015027929A1 Traditional chinese medicine composition
03/05/2015WO2015027911A1 Compound for treating diabetes
03/05/2015WO2015027891A1 New salvianolic acid compound t, preparation method therefor, and use thereof
03/05/2015WO2015027863A1 Applications of substituent benzyloxy group containing ether compounds for preparing antitumor drugs
03/05/2015WO2015027848A1 Method of administering formulation comprising peramivir and/or derivative thereof
03/05/2015WO2015027669A2 Phenyl-substituted compound, pharmaceutical composition and uses thereof
03/05/2015WO2015027667A1 2, 6-di-nitrogen-containing substituted purine derivative, and preparation method, pharmaceutical composition and use thereof
03/05/2015WO2015027565A1 L-carnitine micro-capsule powder and preparation method thereof
03/05/2015WO2015027539A1 Method for preparing stasis-phlegm-type ovarian cysts animal model
03/05/2015WO2015027518A1 Chinese herbal medicine health-care cigarette
03/05/2015WO2015027463A1 Agents for preventing or treating alcoholic fatty liver
03/05/2015WO2015027431A1 2,2-difluorodioxolo a2a receptor antagonists
03/05/2015WO2015027334A1 Antisense-based small rna agents targeting the gag open reading frame of hiv-1 rna
03/05/2015WO2015027324A1 Mao-b selective inhibitor compounds, pharmaceutical compositions thereof and uses thereof
03/05/2015WO2015027303A1 Method for manufacturing a pharmaceutical combination containing an analgesic agent and an antispasmodic agent and pharmaceutical combination
03/05/2015WO2014210596A9 Treating an arrhythmia with an opioid antagonist
03/05/2015WO2014110705A9 Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases
03/05/2015WO2014096864A9 Enzyme inhibitors
03/05/2015US20150065945 Spinal neuromodulation and associated systems and methods
03/05/2015US20150065781 Combination therapy for the treatment of glioblastoma
03/05/2015US20150065714 Production of alkaloids by liliaceae cell culture
03/05/2015US20150065711 Discrete PEG Constructs
03/05/2015US20150065584 Methods Of Use For 2,5-Dihydroxybenzene Sulfonic Acid Compounds For The Treatment Of Cancer, Rosacea And Psoriasis
03/05/2015US20150065582 Orally Dissolving Formulations of Memantine
03/05/2015US20150065581 Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
03/05/2015US20150065580 Application of fluoxetine to treatment of depigmentation diseases
03/05/2015US20150065578 Compositions and Methods for Treating Metabolic Disorders
03/05/2015US20150065577 Method of treating binge eating disorder
03/05/2015US20150065576 Use of amides of mono- and dicarboxylic acids in the treatment of renal diseases
03/05/2015US20150065574 Treatment of atypical hemolytic uremic syndrome
03/05/2015US20150065573 Treatment of age-related macular degeneration
03/05/2015US20150065572 Methods of treating or preventing prostate cancer
03/05/2015US20150065571 Ketone body and ketone body ester for reducing muscle breakdown
03/05/2015US20150065570 Agent for inducing the synthesis of heat-shock proteins in human and animal cells
03/05/2015US20150065569 Method for cancer treatment
03/05/2015US20150065568 Method for producing composition containing fucoxanthin
03/05/2015US20150065566 Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
03/05/2015US20150065565 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/05/2015US20150065561 Compositions and methods for treating otitis media and other conditions with inhibitors of cyld
03/05/2015US20150065559 METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM
03/05/2015US20150065558 Glycoconjugates of RNA Interference Agents
03/05/2015US20150065554 Neurofibromatoses therapeutic agents and screening for same
03/05/2015US20150065553 Stabilized statin formulations
03/05/2015US20150065550 New alpha2 adrenoceptor agonists
03/05/2015US20150065549 Bendamustine Pharmaceutical Compositions
03/05/2015US20150065548 Composition comprising an organic diluent and a cellulose ether
03/05/2015US20150065547 Esterified cellulose ethers having a specific substituent distribution
03/05/2015US20150065545 Transdermal Delivery of Anastrozole for Systemic Effect
03/05/2015US20150065544 Therapeutic agent and preventive agent for demyelinating disease
03/05/2015US20150065539 Methods for Increasing CFTR Activity
03/05/2015US20150065538 Trpa1 antagonists
03/05/2015US20150065536 Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof
03/05/2015US20150065535 Method of restoring the incretin effect
03/05/2015US20150065533 Benzyl-substituted carbamates and use thereof
03/05/2015US20150065528 Paralytic shellfish poison
03/05/2015US20150065526 Overcoming acquired resistance to chemotherapy treatments through suppression of stat3
03/05/2015US20150065525 Methods for improving diaphragm function
03/05/2015US20150065522 Therapeutic compounds and uses thereof
03/05/2015US20150065518 Methods of treating cancer having an active wnt/beta-catenin pathway
03/05/2015US20150065517 New compounds
03/05/2015US20150065514 Methods And Compositions To Reduce Oxidative Stress
03/05/2015US20150065513 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/05/2015US20150065512 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/05/2015US20150065511 Compositions and Methods for the Treatment of Presbyopia
03/05/2015US20150065504 Antiviral compounds
03/05/2015US20150065502 Antibacterial quinoline derivatives
03/05/2015US20150065501 N-substituted hetero-bicyclic furanone derivatives for combating animal
03/05/2015US20150065500 Modulators of ATP-Binding Cassette Transporters
03/05/2015US20150065497 Modulators of atp-binding cassette transporters
03/05/2015US20150065493 Process for preparing sterile brinzolamide
03/05/2015US20150065492 5,6-dihydro-1h-pyridin-2-one compounds
03/05/2015US20150065491 Administration of benzodiazepine compositions
03/05/2015US20150065490 Organic compounds
03/05/2015US20150065488 Methods of treating disorders associated with protein polymerization
03/05/2015US20150065486 Methods for treating polycystic kidney disease
03/05/2015US20150065484 Sustained release dosage forms for a jak1 inhibitor
03/05/2015US20150065479 Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor
03/05/2015US20150065478 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
03/05/2015US20150065474 Dexamethasone formulations in a biodegradable material
03/05/2015US20150065473 Method for visual enhancement and post procedure treatment protocol
03/05/2015US20150065472 Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy
03/05/2015US20150065471 Salts of 5-[(1r)-2-(amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one
03/05/2015US20150065470 Steroid Sulfatase Inhibitor Regimen for the Treatment of Endometriosis
03/05/2015US20150065468 Biaryl acetamide compounds and methods of use thereof
03/05/2015US20150065467 Use of lipid conjugates in the treatment of diseases or disorders of the eye
03/05/2015US20150065466 Novel dxr inhibitors for antimicrobial therapy
03/05/2015US20150065465 Imidazotriazinecarbonitriles useful as kinase inhibitors
03/05/2015US20150065464 Amide compounds, compositions and applications thereof
03/05/2015US20150065462 Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease
03/05/2015US20150065461 Vesicular Formulations for Use in the Treatment of Pain or Reduced Mobility of a Joint
03/05/2015US20150065460 Biomarkers Related to Insulin Resistance and Methods Using the Same
03/05/2015US20150065458 Composition for Inactivating an Enveloped Virus
03/05/2015US20150065457 Method of using cyclodextrin
03/05/2015US20150065456 Agent for treatment and prevention of cancer
03/05/2015US20150065453 Combination of an oxidant and a photoactivator for the healing of wounds
03/05/2015US20150065452 Anti-fatigue composition, formulation and use thereof
03/05/2015US20150065451 Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation
1 2 3 4 5 6 7 8 9 10 11 12 ... 7860